Hospital Acquired Disease Testing Market 2017 - Industry Growth, Analysis, and Forecast To 2022
According to the latest report published by Credence
Research, Inc. “Hospital Acquired Disease Testing Market Growth,
Future Prospects and Competitive Analysis, 2016-2022,” the hospital
acquired disease testing market was valued at USD 523.0 Mn in 2015, and is
expected to reach USD 1,630.0 Mn by 2022, expanding at a CAGR of 5.4% from 2016
to 2022.
Browse the full report Hospital
Acquired Disease Testing: Market Growth, Future Prospects and Competitive
Analysis, 2016-2022 at
Market Insights
Hospital acquired infections/diseases
(HAIs) or nosocomial infections are defined to the infection acquired by
patients during their stay in healthcare settings. Approximately 9.2 out of 100
patients in the U.S. acquire HAI. The most common types of HAIs include
pneumonia, urinary tract infection, bloodstream infection, surgical site
infection and others. HAIs are caused by pathogens among patients with
compromised immune system, and negligence by hospital staff. The significant
morbidity and mortality, the associated management costs and growing pressure
from governing bodies have urged care-givers to devise accurate diagnosis of
HAIs for efficient healthcare provision.
The global hospital acquired disease
testing market is categorized into tests for hospital acquired pneumonia,
urinary tract infection, surgical site infection, bloodstream infection, MRSA
and others. Hospital acquired pneumonia and urinary tract infection together
occupy more over 50% market share in 2015 with a larger set of revenue coming
from urinary tract infection. The prevalence and morbidity associated with
urinary tract infection is the highest among the other infection types and its
diagnosis is the swiftest. It is anticipated that the dominance of this segment
will continue through the forecast period 2016-2022. Other testing tools for
surgical site infections and bloodstream infection are anticipated to undergo
faster growth during the forecast period attributed by their alarming incidence
in the emerging markets.
Geographically, North America is the
largest regional market for hospital acquired disease testing, high
number of hospital stays and the corresponding risk of contracting HAIs majorly
determine the market size of this region. On the other hand, greater awareness
and reducing the incidence of hospital readmission, along with the growing
urgency to control hospital and healthcare costs contribute to the faster
market growth rate of Asia-Pacific and Latin America hospital acquired disease
testing markets.
In view of the market competition,
this market is fragmented with a multitude of companies offering HAI testing
tools. Some of the notable players in the hospital acquired disease testing
market include Diatherix Corp, Roche, Cantel Medical Corporation, Qiagen,
Cephid, bioMeriux and others.
Request free sample – http://www.credenceresearch.com/sample-request/57814
About Us:
Credence Research is a worldwide market research and
counseling firm that serves driving organizations, governments, non-legislative
associations, and not-for-benefits. We offer our customers some assistance with
making enduring enhancements to their execution and understand their most
imperative objectives. Over almost a century, we’ve manufactured a firm
extraordinarily prepared to this task.
Who we are
Credence Research is a worldwide firm, containing more
than 15 research consultants and almost 100 research and information
professionals.
Our customers mirror our worldwide nature. Around 45% are
in Europe, 30% in the Americas, 13% in Asia Pacific and 12% in the Middle East
and Africa.
Our firm is intended to work as one. We are a solitary
global research organization united by a solid arrangement of qualities,
concentrated on customer effect.
What we do
We serve customers at each level of their organization, in
whatever limit we can be most helpful, whether as a trusted counsel to top
management or as a hands-on mentor for forefront representatives. For each
engagement, we collect a group with the most suitable experience and ability.
No matter the challenge, we concentrate on delivering
functional and persevering results, and preparing our customers to develop and
lead. We join forces with customers to place suggestions into practice. Our
research specialist work straightforwardly with customers over long stretches
to create workforce aptitudes, drive operational change, and apply new working
strategies.
Contact:
Name: Chris Smith
Designation: Global Sales Manager
E-mail: sales@credenceresearch.com
Ph: +1-800-361-8290
Post a Comment